The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancer
Aim This study evaluated the prognostic impact of human epidermal growth factor receptor 2 (HER2) status on real-world overall survival (rwOS) in patients with metastatic colorectal cancer (mCRC) who had not received HER2-targeted therapy.Methods This retrospective cohort analysis included patients...
Saved in:
| Main Authors: | Karen Bartley, Jeremy Snider, Cheryl Cho-Phan, Jingru Wang, Peter Martin, Cyndy Simon, Edward Neuberger, Naureen Starling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2025.2527482 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
by: Yan Chen, et al.
Published: (2024-12-01) -
Dynamic changes in serum adenosine and the adenosine metabolism-based signature for prognosis in HER2-positive metastatic breast cancer patients
by: Lijun Wang, et al.
Published: (2024-12-01) -
Real-world effectiveness of palbociclib in HR+/HER2- metastatic breast cancer: a literature review
by: Emilie Adrian Christiansen, et al.
Published: (2024-12-01) -
Development and validation of prognostic nomogram for overall survival in canine multicentric lymphoma: a retrospective study
by: Zeyun Zhu, et al.
Published: (2025-07-01) -
Nomogram prediction of overall survival in patients with bone metastases from hepatocellular carcinoma: a SEER-based retrospective cohort study
by: Qingliang Song, et al.
Published: (2025-07-01)